Literature DB >> 22094531

The effects of acute tryptophan depletion on costly information sampling: impulsivity or aversive processing?

M J Crockett1, L Clark, L D Smillie, T W Robbins.   

Abstract

RATIONALE: The neurotransmitter serotonin (5-HT) has been implicated in both aversive processing and impulsivity. Reconciling these accounts, recent studies have demonstrated that 5-HT is important for punishment-induced behavioural inhibition. These studies focused on situations where actions lead directly to punishments. However, decision-making often involves making tradeoffs between small 'local' costs and larger 'global' losses.
OBJECTIVE: We aimed to distinguish whether 5-HT promotes avoidance of local losses, global losses, or both, in contrast to an overall effect on reflection impulsivity. We further examined the influence of individual differences in sub-clinical depression, anxiety and impulsivity on global and local loss avoidance.
METHODS: Healthy volunteers (N = 21) underwent an acute tryptophan depletion procedure in a double-blind, placebo-controlled crossover design. We measured global and local loss avoidance in a decision-making task where subjects could sample information at a small cost to avoid making incorrect decisions, which resulted in large losses.
RESULTS: Tryptophan depletion removed the suppressive effects of small local costs on information sampling behaviour. Sub-clinical depressive symptoms produced effects on information sampling similar to (but independent from) those of tryptophan depletion. Dispositional anxiety was related to global loss avoidance. However, trait impulsivity was unrelated to information sampling.
CONCLUSIONS: The current findings are consistent with recent theoretical work that characterises 5-HT as pruning a tree of potential decisions, eliminating options expected to lead to aversive outcomes. Our results extend this account by proposing that 5-HT promotes reflexive avoidance of relatively immediate aversive outcomes, potentially at the expense of more globally construed future losses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22094531      PMCID: PMC3291823          DOI: 10.1007/s00213-011-2577-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  53 in total

Review 1.  On serotonin and experimental anxiety.

Authors:  Frederico G Graeff
Journal:  Psychopharmacology (Berl)       Date:  2002-06-05       Impact factor: 4.530

2.  Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior.

Authors:  Catharine A Winstanley; Jeffrey W Dalley; David E H Theobald; Trevor W Robbins
Journal:  Neuropsychopharmacology       Date:  2004-07       Impact factor: 7.853

3.  Distinguishing between learning and motivation in behavioral tests of the reinforcement sensitivity theory of personality.

Authors:  Luke D Smillie; Len I Dalgleish; Chris J Jackson
Journal:  Pers Soc Psychol Bull       Date:  2007-03-15

4.  Effect of the oral administration of tryptophan-free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism.

Authors:  G L Gessa; G Biggio; F Fadda; G U Corsini; A Tagliamonte
Journal:  J Neurochem       Date:  1974-05       Impact factor: 5.372

Review 5.  Serotonin and dopamine: unifying affective, activational, and decision functions.

Authors:  Roshan Cools; Kae Nakamura; Nathaniel D Daw
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

6.  Is this happiness I see? Biases in the identification of emotional facial expressions in depression and social phobia.

Authors:  Jutta Joormann; Ian H Gotlib
Journal:  J Abnorm Psychol       Date:  2006-11

7.  A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.

Authors:  Mary C Zanarini; Frances R Frankenburg; Elizabeth A Parachini
Journal:  J Clin Psychiatry       Date:  2004-07       Impact factor: 4.384

Review 8.  Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.

Authors:  M J Owens; C B Nemeroff
Journal:  Clin Chem       Date:  1994-02       Impact factor: 8.327

Review 9.  Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

Authors:  E Gouzoulis-Mayfrank; J Daumann
Journal:  Addiction       Date:  2006-03       Impact factor: 6.526

10.  Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis.

Authors:  Shashwath A Meda; Michael C Stevens; Marc N Potenza; Brian Pittman; Ralitza Gueorguieva; Melissa M Andrews; Andre D Thomas; Christine Muska; Jennifer L Hylton; Godfrey D Pearlson
Journal:  Behav Pharmacol       Date:  2009-09       Impact factor: 2.293

View more
  10 in total

1.  The good, the bad and the brain: Neural correlates of appetitive and aversive values underlying decision making.

Authors:  Mathias Pessiglione; Mauricio R Delgado
Journal:  Curr Opin Behav Sci       Date:  2015-08-24

Review 2.  Impulsivity and apathy in Parkinson's disease.

Authors:  Nihal Sinha; Sanjay Manohar; Masud Husain
Journal:  J Neuropsychol       Date:  2013-04-29       Impact factor: 2.864

3.  Self-reported and neurocognitive impulsivity in obsessive-compulsive disorder.

Authors:  Ilana Frydman; Paulo Mattos; Ricardo de Oliveira-Souza; Murat Yücel; Samuel R Chamberlain; Jorge Moll; Leonardo F Fontenelle
Journal:  Compr Psychiatry       Date:  2019-12-16       Impact factor: 3.735

4.  Selective effects of serotonin on choices to gather more information.

Authors:  James Ja Livermore; Clare L Holmes; Jo Cutler; Maruša Levstek; Gyorgy Moga; James Rc Brittain; Daniel Campbell-Meiklejohn
Journal:  J Psychopharmacol       Date:  2021-02-18       Impact factor: 4.153

5.  Theory of choice in bandit, information sampling and foraging tasks.

Authors:  Bruno B Averbeck
Journal:  PLoS Comput Biol       Date:  2015-03-27       Impact factor: 4.475

6.  Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications.

Authors:  Alejandro Szmulewicz; Cecilia Samamé; Pablo Caravotta; Diego J Martino; Ana Igoa; Diego Hidalgo-Mazzei; Francesc Colom; Sergio A Strejilevich
Journal:  Int J Bipolar Disord       Date:  2016-02-16

7.  A specific role for serotonin in overcoming effort cost.

Authors:  Florent Meyniel; Guy M Goodwin; Jf William Deakin; Corinna Klinge; Christine MacFadyen; Holly Milligan; Emma Mullings; Mathias Pessiglione; Raphaël Gaillard
Journal:  Elife       Date:  2016-11-08       Impact factor: 8.140

8.  Peripheral Serotonin 1B Receptor Transcription Predicts the Effect of Acute Tryptophan Depletion on Risky Decision-Making.

Authors:  Paul Faulkner; Federico Mancinelli; Patricia L Lockwood; Mar Matarin; Raymond J Dolan; Nick W Wood; Peter Dayan; Jonathan P Roiser
Journal:  Int J Neuropsychopharmacol       Date:  2017-01-01       Impact factor: 5.176

9.  Dopamine manipulations drive changes in information sampling in healthy volunteers.

Authors:  Raquel Vicario-Feliciano; Rebekah L Wigton; Thomas P White; Sukhi S Shergill; Bruno B Averbeck
Journal:  J Psychopharmacol       Date:  2019-01-15       Impact factor: 4.153

Review 10.  New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity.

Authors:  Naomi A Fineberg; Samuel R Chamberlain; Anna E Goudriaan; Dan J Stein; Louk J M J Vanderschuren; Claire M Gillan; Sameer Shekar; Philip A P M Gorwood; Valerie Voon; Sharon Morein-Zamir; Damiaan Denys; Barbara J Sahakian; F Gerard Moeller; Trevor W Robbins; Marc N Potenza
Journal:  CNS Spectr       Date:  2014-02       Impact factor: 3.790

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.